.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

The Long Game: Management Strategies in Kidney Cancer

EP. 1: Heterogeneity of Kidney Cancer

September 8th 2017

EP. 2: Molecular Profiling in Renal Cell Carcinoma

September 8th 2017

EP. 3: Recent Data in the Adjuvant Setting of RCC

September 8th 2017

EP. 4: Risk of Postsurgical Disease Recurrence in RCC

September 8th 2017

EP. 5: RCC: Resection in Metastatic Disease

September 8th 2017

EP. 6: Frontline Decisions in Metastatic Kidney Cancer

September 8th 2017

EP. 7: Defining Progression in Kidney Cancer

September 8th 2017

EP. 8: Second-Line Decision-Making in Kidney Cancer

September 8th 2017

EP. 9: RCC: Following Patients on Immunotherapy Vs TKI Therapy

September 8th 2017

EP. 10: Frontline Clinical Trials in Renal Cell Carcinoma

September 8th 2017

EP. 11: Emerging Immunotherapy Combinations in Kidney Cancer

September 8th 2017

EP. 12: Role of PD-L1 Testing in Kidney Cancer

September 8th 2017